News
Second COVID-19 antiviral set for release
The UK’s second ground-breaking antiviral–Pfizer’s Paxlovid (ritonavir)–will be accessible to thousands of the country’s most vulnerable patients.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
The UK’s second ground-breaking antiviral–Pfizer’s Paxlovid (ritonavir)–will be accessible to thousands of the country’s most vulnerable patients.